hypertonus, intrapartum fetal anoxia, rapid labour, and deep transverse arrest of the fetal head. We therefore made a limited comparison between the methods of delivery used in this study and for 945 women of similar gestation and in whom there was no clinical suspicion of cephalopelvic disproportion and who were delivered in the same hospital during 1973. In both groups all labours were induced by an identical technique, except that in 1973 once labour became established the oxytocin infusion rate was not reduced to 7 mU/min but was maintained at a greater though constant rate.
hypertonus, intrapartum fetal anoxia, rapid labour, and deep transverse arrest of the fetal head. We therefore made a limited comparison between the methods of delivery used in this study and for 945 women of similar gestation and in whom there was no clinical suspicion of cephalopelvic disproportion and who were delivered in the same hospital during 1973. In both groups all labours were induced by an identical technique, except that in 1973 once labour became established the oxytocin infusion rate was not reduced to 7 mU/min but was maintained at a greater though constant rate.
The incidence of normal delivery was similar in both groups. In the present study no ventouse extractions were necessary and no caesarean sections were performed. In 1973 3% of the patients were delivered by these methods. Fetal distress was never the indication for operative intervention in patients receiving only 7mU oxytocin/min to maintain labour. In 1973 fetal distress, confirmed by blood pH estimation, was the chief indication for operative delivery in 32% of the group.
Whereas variable amounts of oxytocin are required to induce labour to the stage of 5 cm dilatation of the cervix within a reasonably short time, our results show that no more than 7 mU/min is necessary to maintain labour satisfactorily thereafter. Larger doses at this time may be attended by obstetric problems. We therefore recommend the adoption of a maintenance regimen whenever established labour has been induced.
Introduction
Carfecillin (Uticillin) is the phenyl ester of carbenicillin substituted in the x-carboxyl position on the active side chain, which greatly increases the oral absorption of the drug. Esterification is a well-known method of increasing the absorption of antibiotics from the gastrointestinal tract-for example, the esters of erythromycin. Once absorbed, carfecillin is rapidly hydrolysed to carbenicillin and phenol,' the phenol moiety being quickly detoxicated by conjugation as glucuronide and sulphate and excreted in the urine. Excretion of the antibiotic is predominantly renal and high levels of carbenicillin appear in the urine though the relatively short serum half life, even in severe renal failure,2 would suggest either a natural loss of antipseudomonal activity in vivo or else an extrarenal pathway of excretion.
This study was designed to investigate the human pharmacology and toxicology of carfeciJlin and assess the drug's value in treating urinary infections in hospital inpatients, particularly those in whom Pseudomonas aeruginosa was the causative pathogen.
Patients and Methods

VOLUNTEER STUDY
Carfecillin 500 mg or 1000 mg by mouth (equivalent to 397 mg and 794 mg of carbenicillin free acid respectively) was given to 10 healthy volunteers two hours after a light breakfast of beverage and toast. Carbenicillin levels were assayed in serial blood samples over eight hours during which about 125 ml of water was allowed every half hour. Urinary recovery of carbenicillin was measured over three consecutive four-hour periods from the beginning of the study. All serum and urine carbenicillin concentrations were assayed by a wellplate microbiological diffusion assay method using Ps. aeruginosa (NCTC 10490) as test organism. Serum samples were also investigated for the presence of free phenol by a standard gas-liquid chromatographic method, using an ether/acid extraction process which could detect less than 0-5 mg/l free phenol.
Four of the volunteers subsequently took either 500 mg or 1000 mg of carfecillin every eight hours over four days while receiving their normal diet. Serial carbenicillin levels were determined as before on days two and four, and all urine was collected for assay throughout the period.
Four patients with renal failure (creatinine clearance < 2-2 ml/min) who had given informed consent took either two or three doses of carfecillin 1000 mg by mouth at four-hourly intervals. Serum carbenicillin levels were assayed throughout the period. Two of the patients were anuric, so urinary carbenicillin levels were measured only in two. Further urine samples were cultured after 14 and 42 days. Eradication of the initial pathogen at both these times was considered to be the criterion of bacteriological cure. The minimum inhibitory concentration (M.I.C.) of carbenicillin for each of the isolates was determined by a standard agar dilution method.
Full haematological indices, plasma urea, serum transaminases, and liver function were determined for all volunteers and patients at the beginning and end of each study or course of treatment.
Results
PHARMACOLOGY Serum Levels
Serum levels of carbenicillin in the healthy volunteers varied considerably, but peak levels were less than 10 mg/l in all cases (see fig.) . After four to six hours the drug was undetectable in many cases. Levels of up to 9-8 mg/l were found two hours after taking 1000 mg of carfecillin on days two and four in healthy volunteers taking the four-day course.
Z-
Mean serum levels of carbenicillin (and ranges) after singl of carfecillin in 10 healthy volunteers. 251 one hour, mean 6-7 mg/l, range 0-18-5 mg/l; at two hours, mean 7-6 mg/l, range 1-8-15-0 mg/l). This was to be expected from the variation in the patients' renal function (creatinine clearance 14-119 ml/min), and the difficulty of standardizing the timing of the dose with respect to mealtimes.
Urinary Levels
The urinary carbenicillin levels in healthy volunteers varied greatly after a single dose of carfecillin. Maximum excretion was in the first four hours when mean levels were 112 mg/l after 500 mg (range 54-180 mg/l) and 434 mg/l after 1000 mg (range mgfl). One of the two non-anuric patients with renal failure had a level of 49 mg/l in a 12-hour collection of urine, and no antibiotic was detected in the urine of the other. About 25% of the carbenicillin equivalent of the administered dose was excreted in the urine on each dosage regimen, which is in agreement with the results of Jones. In the four patients with severe renal failure the dosage regimen was designed to ascertain whether poor renal function would enable serum levels adequate for systemic antipseudomonal activity to be achieved. A shorter dose interval (4 hours) was therefore adopted, and considerably higher concentrations were obtained, which seemed to reach a plateau after the third four-hourly dose of 1000 mg. With the small numbers no statistically significant difference was found between the mean two-hour carbenicillin concentrations after a single dose of 1000 mg of carfecillin in the four healthy volunteers (mean 5-1 mg/l) and in the four renal failure patients (mean Serum levels in volunteers and patients after oral carfecillin were found to be insufficient to treat systemic infection with Ps. aeruginosa, even when renal function was impaired, but urinary levels were sufficient to suggest that urinary infections might be eradicated.
In severe renal failure the mean serum half life of carbenicillin is only [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] hours,2 which is short compared with that of gentamicin Lees and Harding'0 noted that 10-5% of patients who were given carfecillin capsules had diarrhoea, but only 4-35% who received the tablet form (as now marketed) complained of this side effect.
Our results compare favourably with those of Berrill et al,7
particularly as our dose was lower and given for seven days instead of 14. Our patients also had a high prevalence of urinary tract abnormalities. The overall cure rate with indanyl carbenicillin in the series of Ries et al. 9 was 50% as compared with 60% in our series, though no pseudomonas infections were treated with indanyl carbenicillin in the former series as compared with 12 in ours. Ps. aeruginosa rarely causes primary, uncomplicated urinary tract infection but it may cause infection secondary to other urinary tract conditions or operations where catheterization may have been necessary."' The only antibiotic therapy available to such patients is by the parenteral route, which usually means a stay in hospital. The availability of a well-tolerated oral agent for such cases represents a therapeutic advance. Further studies with carfecillin are necessary, and possibly a longer course of treatment should be given in difficult cases, but this drug promises to be a useful oral treatment of urinary infections when the choice of effective antibiotics is limited.
The formulation of carfecillin to be marketed in the United Kingdom will differ slightly from that used in our studies reported here, the main change being improved oral absorption.3 Its performance in curing infection will probably be at least as good as that of the previous formulation, but side effects and tolerability will need to be reassessed.
Introduction
Renal injury in most patients with Goodpasture's syndrome is known to be mediated by antibodies directed at the glomerular basement membrance (G.B.M.).1-3 This syndrome-the association of lung haemorrhage and glomerulonephritis-is characterized by a rapidly fatal course terminating in renal failure or asphyxia from uncontrolled lung haemorrhage. Since
